FDA Drug Safety Podcast: FDA warns about rare but serious allergic reactions with the skin antiseptic chlorhexidine gluconate
On February 2, 2017, the FDA announced it is warning that rare but serious allergic reactions have been reported with the widely used skin antiseptic products containing chlorhexidine gluconate. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 8, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
The Primary Endpoint Is Negative: What Happens Now?
Stuart Pocock reviews 12 key considerations when the outcome of a clinical trial is negative, using familiar trials to illustrate these points. Can the data be salvaged, or is it a ' no-hoper ' ? (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 6, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
FDA Drug Safety Podcast: FDA revises description of mental health side effects of stop-smoking medicines Chantix and Zyban to reflect clinical trial findings
On December 16, 2016, the FDA announced that based on our review of a large clinical trial that we required the drug companies to conduct, we have determined the risk of serious side effects on mood, behavior, or thinking with the stop-smoking medicines Chantix (active ingredient varenicline) and Zyban (active ingredient bupropion) is lower than previously suspected. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 28, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: Updated FDA review concludes that use of pioglitazone may be linked to an increased risk of bladder cancer
On December 12, 2016, FDA announced as a result of an updated review, that it has concluded that use of the type 2 diabetes medicine pioglitazone (brand names Actos, Actoplus Met, Actoplus Met XR, Duetact, Oseni) may be linked to an increased risk of bladder cancer. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 28, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women
On December 14, 2016, FDA is warning that repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years or in pregnant women during their third trimester may affect the development of children ’s brains. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 28, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
'Incredibly Exciting': Diabetes Drug With CV Benefits
The FDA ' s recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - December 21, 2016 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
How to Choose a Basal Insulin
So many choices! A diabetes expert provides tips on selecting a basal insulin for a patient with diabetes. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - December 12, 2016 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Antibiotic Stewardship in the Outpatient Setting
New guidelines help clinicians apply best antibiotic-prescribing practices in a range of outpatient settings. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - November 14, 2016 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Do You Know What Supplements Your Patients Are Using?
Dr Bhargava advises us to talk to our patients about the dangers of taking certain supplements. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - October 31, 2016 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
FDA Drug Safety Podcast: FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C
On October 4, 2016, FDA announced it is warning about the risk of hepatitis B virus (HBV) becoming an active infection again in any patient who has a current or previous infection with HBV and is treated with certain direct-acting antiviral (DAA) medicines for hepatitis C virus. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - October 7, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning
On August 31, 2016, FDA announced that a review has found that the growing use of combining opioid medicines with benzodiazepines and other drugs that depress the central nervous system (CNS) has resulted in serious side effects, including slowed or difficult breathing and deaths. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - September 7, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Patient Interest in CAM: A Rapidly Growing Trend
Patients using CAM therapies might not always share with their healthcare provider which therapies they are using. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - August 16, 2016 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
FDA Drug Safety Podcast: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects
On July 26, 2016, FDA approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection). (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - August 2, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Best of ASCO 2016: Melanoma
John Fruehauf, MD, phd Director Clinical pharmacology and developmental therapeutics UCI Irvine Comprehensive cancer center goes over the best data released at this year's ASCO 2016 concerning melanom...
Author: moasc
Added: 07/16/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2016 Category: Cancer & Oncology Source Type: podcasts
'Profound' Finding on Continuous Glucose Monitoring
Do patients with type 1 diabetes benefit from continuous glucose monitoring even if they are not using an insulin pump? (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - July 14, 2016 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
